Click for best price
Postpemic Era Lung Cancer Liquid Biops Market Size, Share 2022
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Global Lung Cancer Liquid Biops Market Segment Research Report 2022?, which aims to sort out the development status and trends of the Lung Cancer Liquid Biops industry at home and abroad, estimate the overall market scale of the Lung Cancer Liquid Biops industry and the market share of major countries, Lung Cancer Liquid Biops industry, and study and judge the downstream market demand of Lung Cancer Liquid Biops through systematic research, Analyze the competition pattern of Lung Cancer Liquid Biops, so as to help solve the pain points of various stakeholders in Lung Cancer Liquid Biops industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Lung Cancer Liquid Biops Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Lung Cancer Liquid Biops Market?
Biocept
EntroGen
Cynvenio Biosystems
Exosome Diagnostics
F. Hoffmann-La Roche
Clearbridge BioMedics
Bio-Rad Laboratories
Agena Bioscience
Cancer Genetics
CellMax Life
Nateras
MedGenome
OncoDNA
Genomic Health
Trovagene
Fluxion Biosciences
Biodesix
Epic Sciences
Shuwen Biotech
Personal Genome Diagnostics
Predicine
Major Type of Lung Cancer Liquid Biops Covered in XYZResearch report:
Exosomes and RNA
CTCs and ctDNA
Application Segments Covered in XYZResearch Market
Hospitals and Clinics
Physicians'Office Laboratories
Clinical Diagnostic Laboratories
For any other requirements, please feel free to contact us and we will provide you customized report.
| Report Attributes |
Report Details |
| Report Title |
(Post-pandemic Era)-Global Lung Cancer Liquid Biops Market Segment Research Report 2022 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
124 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
Table of Contents
Global Lung Cancer Liquid Biops Market Segment Research Report 2022
1. Research Scope
2. Market Overview
2.1 Product Introduction, Application, Picture
2.2 Global Lung Cancer Liquid Biops Market by Value
2.2.1 Global Lung Cancer Liquid Biops Revenue by Type
2.2.2 Global Lung Cancer Liquid Biops Market by Value (%)
2.3 Global Lung Cancer Liquid Biops Market by Production
2.3.1 Global Lung Cancer Liquid Biops Production by Type
2.3.2 Global Lung Cancer Liquid Biops Market by Production (%)
3. The Major Driver of Lung Cancer Liquid Biops Industry
3.1 Historical & Forecast Global Lung Cancer Liquid Biops Demand
3.2 Largest Application for Lung Cancer Liquid Biops (2018-2028)
3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Lung Cancer Liquid Biops Market
4.1 Regional Market Size in Terms of Production & Demand (2022)
4.2 Regional Market Share in Terms of Revenue (2018-2022)
4.3 Concentration Ratio (CR5& CR10) of Lung Cancer Liquid Biops Market
4.4 Mergers & Acquisitions, Expansion Plans
5. US Lung Cancer Liquid Biops Production, Demand (2018-2028)
5.1 Current and Estimated Production Breakdown by Type
5.2 Current and Estimated Demand Breakdown by Type
5.3 Current and Estimated Demand Breakdown by Application
5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Lung Cancer Liquid Biops Production, Demand (2018-2028)
6.1 Current and Estimated Production Breakdown by Type
6.2 Current and Estimated Demand Breakdown by Type
6.3 Current and Estimated Demand Breakdown by Application
6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Lung Cancer Liquid Biops Production, Demand (2018-2028)
7.1 Current and Estimated Production Breakdown by Type
7.2 Current and Estimated Demand Breakdown by Type
7.3 Current and Estimated Demand Breakdown by Application
7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Lung Cancer Liquid Biops Production, Demand (2018-2028)
8.1 Current and Estimated Production Breakdown by Type
8.2 Current and Estimated Demand Breakdown by Type
8.3 Current and Estimated Demand Breakdown by Application
8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Lung Cancer Liquid Biops Production, Demand (2018-2028)
9.1 Current and Estimated Production Breakdown by Type
9.2 Current and Estimated Demand Breakdown by Type
9.3 Current and Estimated Demand Breakdown by Application
9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Lung Cancer Liquid Biops Production, Demand (2018-2028)
10.1 Current and Estimated Production Breakdown by Type
10.2 Current and Estimated Demand Breakdown by Type
10.3 Current and Estimated Demand Breakdown by Application
10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Lung Cancer Liquid Biops Production, Demand (2018-2028)
11.1 Current and Estimated Production Breakdown by Type
11.2 Current and Estimated Demand Breakdown by Type
11.3 Current and Estimated Demand Breakdown by Application
11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Lung Cancer Liquid Biops Average Price Trend
12.1 Market Price for Each Type of Lung Cancer Liquid Biops in US (2018-2022)
12.2 Market Price for Each Type of Lung Cancer Liquid Biops in Europe (2018-2022)
12.3 Market Price for Each Type of Lung Cancer Liquid Biops in China (2018-2022)
12.4 Market Price for Each Type of Lung Cancer Liquid Biops in Japan (2018-2022)
12.5 Market Price for Each Type of Lung Cancer Liquid Biops in India (2018-2022)
12.6 Market Price for Each Type of Lung Cancer Liquid Biops in Korea (2018-2022)
12.7 Market Price for Each Type of Lung Cancer Liquid Biops in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
13.1 Lung Cancer Liquid Biops Industrial Chain Analysis
13.2 Downstream
13.3 Impact of COVID-19
13.4 Post-pandemic Era
13.5 Technology Trends of Lung Cancer Liquid Biops
14. Lung Cancer Liquid Biops Competitive Landscape
14.1 Biocept
14.1.1 Biocept Company Profiles
14.1.2 Biocept Product Introduction
14.1.3 Biocept Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.1.4 Strategic initiatives
14.2 EntroGen
14.2.1 EntroGen Company Profiles
14.2.2 EntroGen Product Introduction
14.2.3 EntroGen Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.2.4 Strategic initiatives
14.3 Cynvenio Biosystems
14.3.1 Cynvenio Biosystems Company Profiles
14.3.2 Cynvenio Biosystems Product Introduction
14.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.3.4 Strategic initiatives
14.4 Exosome Diagnostics
14.4.1 Exosome Diagnostics Company Profiles
14.4.2 Exosome Diagnostics Product Introduction
14.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.4.4 Strategic initiatives
14.5 F. Hoffmann-La Roche
14.5.1 F. Hoffmann-La Roche Company Profiles
14.5.2 F. Hoffmann-La Roche Product Introduction
14.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.5.4 Strategic initiatives
14.6 Clearbridge BioMedics
14.6.1 Clearbridge BioMedics Company Profiles
14.6.2 Clearbridge BioMedics Product Introduction
14.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.6.4 Strategic initiatives
14.7 Bio-Rad Laboratories
14.7.1 Bio-Rad Laboratories Company Profiles
14.7.2 Bio-Rad Laboratories Product Introduction
14.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.7.4 Strategic initiatives
14.8 Agena Bioscience
14.8.1 Agena Bioscience Company Profiles
14.8.2 Agena Bioscience Product Introduction
14.8.3 Agena Bioscience Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.8.4 Strategic initiatives
14.9 Cancer Genetics
14.9.1 Cancer Genetics Company Profiles
14.9.2 Cancer Genetics Product Introduction
14.9.3 Cancer Genetics Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.9.4 Strategic initiatives
14.10 CellMax Life
14.10.1 CellMax Life Company Profiles
14.10.2 CellMax Life Product Introduction
14.10.3 CellMax Life Lung Cancer Liquid Biops Sales, Revenue (2018-2022)
14.10.4 Strategic initiatives
14.11 Nateras
14.12 MedGenome
14.13 OncoDNA
14.14 Genomic Health
14.15 Trovagene
14.16 Fluxion Biosciences
14.17 Biodesix
14.18 Epic Sciences
14.19 Shuwen Biotech
14.20 Personal Genome Diagnostics
14.21 Predicine
15. Conclusion
16. Methodology and Data Source
LIST OF TABLES & FIGURES
List of Tables and Figures
Figure 1. Total Demand by Application of Lung Cancer Liquid Biops Industry (Volume)
Figure 2. Lung Cancer Liquid Biops Production & Demand by Regions in 2022
Figure 3. Regional Market Share in Terms of Revenue (2022&2027)
Figure 4. The Top 10 and 5 Players Market Share by Lung Cancer Liquid Biops Revenue in 2022
Figure 5. US Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 6. Production Breakdown by Type (%)
Figure 7. Demand Breakdown by Type (%)
Figure 8. Demand Breakdown by Application (%)
Figure 9. Revenue Breakdown by Type (%)
Figure 10. Revenue Breakdown by Application (%)
Figure 11. Europe Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 12. Production Breakdown by Type (%)
Figure 13. Demand Breakdown by Type (%)
Figure 14. Demand Breakdown by Application (%)
Figure 15. Revenue Breakdown by Type (%)
Figure 16. Revenue Breakdown by Application (%)
Figure 17. China Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 18. Production Breakdown by Type (%)
Figure 19. Demand Breakdown by Type (%)
Figure 20. Demand Breakdown by Application (%)
Figure 21. Current and Estimated Revenue Breakdown by Type
Figure 22. Revenue Breakdown by Type (%)
Figure 23. Revenue Breakdown by Application (%)
Figure 24. Japan Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 25. Production Breakdown by Type (%)
Figure 26. Demand Breakdown by Type (%)
Figure 27. Demand Breakdown by Application (%)
Figure 28. Revenue Breakdown by Type (%)
Figure 29. Revenue Breakdown by Application (%)
Figure 30. India Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 31. Production Breakdown by Type (%)
Figure 32. Demand Breakdown by Type (%)
Figure 33. Demand Breakdown by Application (%)
Figure 34. Revenue Breakdown by Type (%)
Figure 35. Revenue Breakdown by Application (%)
Figure 36. Korea Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 37. Production Breakdown by Type (%)
Figure 38. Demand Breakdown by Type (%)
Figure 39. Demand Breakdown by Application (%)
Figure 40. Revenue Breakdown by Type (%)
Figure 41. Revenue Breakdown by Application (%)
Figure 42. Southeast Asia Lung Cancer Liquid Biops Production, Demand (2018-2028)
Figure 43. Current and Estimated Production Breakdown by Type (2018-2028)
Figure 44. Production Breakdown by Type (%)
Figure 45. Demand Breakdown by Type (%)
Figure 46. Revenue Breakdown by Type (%)
Figure 47. Revenue Breakdown by Application (%)
Figure 48. Industrial Chain
Table 1. Top Manufacturers and Market Segmentation
Table 2. Product Introduction, Application, Picture
Table 3. Lung Cancer Liquid Biops Revenue, by Type (Million USD) (2018-2028)
Table 4. Lung Cancer Liquid Biops Production, by Type (K Unit) (2018-2028)
Table 5. Lung Cancer Liquid Biops Demand (K Unit) by Application (2018-2028)
Table 6. Lung Cancer Liquid Biops Demand (Million USD) by Application (2018-2028)
Table 7. The Major Downstream Company in China
Table 8. Regional Market Share in Terms of Production & Demand (2022)
Table 9. Regional Market Share in Terms of Revenue (2022&2027)
Table 10. Ranking of Global Top Lung Cancer Liquid Biops Companies by Revenue, Concentration Ratio in 2022
Table 11. Mergers & Acquisitions, Expansion Plans
Table 12. US Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 13. Current and Estimated Production Breakdown by Type (2018-2028)
Table 14. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 15. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 16. Current and Estimated Revenue Breakdown by Type
Table 17. Current and Estimated Revenue Breakdown by Application
Table 18. Europe Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 19. Current and Estimated Production Breakdown by Type (2018-2028)
Table 20. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 21. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 22. Current and Estimated Revenue Breakdown by Type
Table 23. Current and Estimated Revenue Breakdown by Application
Table 24. China Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 25. Table Current and Estimated Production Breakdown by Type
Table 26. Current and Estimated Demand Breakdown by Type
Table 27. Current and Estimated Demand Breakdown by Application
Table 28. Current and Estimated Revenue Breakdown by Application
Table 29. Japan Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 30. Current and Estimated Production Breakdown by Type (2018-2028)
Table 31. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 32. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 33. Current and Estimated Revenue Breakdown by Type
Table 34. Current and Estimated Revenue Breakdown by Application
Table 35. India Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 36. Current and Estimated Production Breakdown by Type (2018-2028)
Table 37. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 38. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 39. Current and Estimated Revenue Breakdown by Type
Table 40. Current and Estimated Revenue Breakdown by Application
Table 41. Korea Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 42. Current and Estimated Production Breakdown by Type (2018-2028)
Table 43. Current and Estimated Demand Breakdown by Type (2018-2028)
Table 44. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 45. Current and Estimated Revenue Breakdown by Type
Table 46. Current and Estimated Revenue Breakdown by Application
Table 47. Southeast Asia Lung Cancer Liquid Biops Production (K Unit), Market Revenue (Million USD), Demand (K Unit) (2018-2028)
Table 48. Table Current and Estimated Demand Breakdown by Type (2018-2028)
Table 49. Current and Estimated Demand Breakdown by Application (2018-2028)
Table 50. Current and Estimated Revenue Breakdown by Type
Table 51. Current and Estimated Revenue Breakdown by Application
Table 52. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in US (2018-2022)
Table 53. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in Europe (2018-2022)
Table 54. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in China (2018-2022)
Table 55. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in Japan (2018-2022)
Table 56. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in India (2018-2022)
Table 57. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in Korea (2018-2022)
Table 58. Market Price (USD/Unit) for Each Type of Lung Cancer Liquid Biops in Southeast Asia (2018-2022)
Table 59. Key Downstream Customer in Each Application Field
Table 60. Biocept Profiles
Table 61. Biocept Lung Cancer Liquid Biops Product Introduction
Table 62. Biocept Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 63. Biocept Strategic initiatives
Table 64. EntroGen Profiles
Table 65. EntroGen Lung Cancer Liquid Biops Product Introduction
Table 66. EntroGen Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 67. EntroGen Strategic initiatives
Table 68. Cynvenio Biosystems Profiles
Table 69. Cynvenio Biosystems Lung Cancer Liquid Biops Product Introduction
Table 70. Cynvenio Biosystems Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 71. Cynvenio Biosystems Strategic initiatives
Table 72. Exosome Diagnostics Profiles
Table 73. Exosome Diagnostics Lung Cancer Liquid Biops Product Introduction
Table 74. Exosome Diagnostics Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 75. Exosome Diagnostics Strategic initiatives
Table 76. F. Hoffmann-La Roche Profiles
Table 77. F. Hoffmann-La Roche Lung Cancer Liquid Biops Product Introduction
Table 78. F. Hoffmann-La Roche Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 79. F. Hoffmann-La Roche Strategic initiatives
Table 80. Clearbridge BioMedics Profiles
Table 81. Clearbridge BioMedics Lung Cancer Liquid Biops Product Introduction
Table 82. Clearbridge BioMedics Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 83. Clearbridge BioMedics Strategic initiatives
Table 84. Bio-Rad Laboratories Profiles
Table 85. Bio-Rad Laboratories Lung Cancer Liquid Biops Product Introduction
Table 86. Bio-Rad Laboratories Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 87. Bio-Rad Laboratories Strategic initiatives
Table 88. Agena Bioscience Profiles
Table 89. Agena Bioscience Lung Cancer Liquid Biops Product Introduction
Table 90. Agena Bioscience Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 91. Agena Bioscience Strategic initiatives
Table 92. Cancer Genetics Profiles
Table 93. Cancer Genetics Lung Cancer Liquid Biops Product Introduction
Table 94. Cancer Genetics Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 95. Cancer Genetics Strategic initiatives
Table 97. CellMax Life Profiles
Table 98. CellMax Life Lung Cancer Liquid Biops Product Introduction
Table 99. CellMax Life Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 100. CellMax Life Strategic initiatives
Table 101. Nateras Profiles
Table 102. Nateras Lung Cancer Liquid Biops Product Introduction
Table 103. Nateras Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 104. Nateras Strategic initiatives
Table 105. MedGenome Profiles
Table 106. MedGenome Lung Cancer Liquid Biops Product Introduction
Table 107. MedGenome Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 108. MedGenome Strategic initiatives
Table 109. OncoDNA Profiles
Table 110. OncoDNA Lung Cancer Liquid Biops Product Introduction
Table 111. OncoDNA Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 112. OncoDNA Strategic initiatives
Table 113. Genomic Health Profiles
Table 114. Genomic Health Lung Cancer Liquid Biops Product Introduction
Table 115. Genomic Health Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 116. Genomic Health Strategic initiatives
Table 117. Trovagene Profiles
Table 118. Trovagene Lung Cancer Liquid Biops Product Introduction
Table 119. Trovagene Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 120. Trovagene Strategic initiatives
Table 121. Fluxion Biosciences Profiles
Table 122. Fluxion Biosciences Lung Cancer Liquid Biops Product Introduction
Table 123. Fluxion Biosciences Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 124. Fluxion Biosciences Strategic initiatives
Table 125. Biodesix Profiles
Table 126. Biodesix Lung Cancer Liquid Biops Product Introduction
Table 127. Biodesix Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 128. Biodesix Strategic initiatives
Table 129. Epic Sciences Profiles
Table 130. Epic Sciences Lung Cancer Liquid Biops Product Introduction
Table 131. Epic Sciences Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 132. Epic Sciences Strategic initiatives
Table 133. Shuwen Biotech Profiles
Table 134. Shuwen Biotech Lung Cancer Liquid Biops Product Introduction
Table 135. Shuwen Biotech Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 136. Shuwen Biotech Strategic initiatives
Table 137. Personal Genome Diagnostics Profiles
Table 138. Personal Genome Diagnostics Lung Cancer Liquid Biops Product Introduction
Table 139. Personal Genome Diagnostics Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 140. Personal Genome Diagnostics Strategic initiatives
Table 141. Predicine Profiles
Table 142. Predicine Lung Cancer Liquid Biops Product Introduction
Table 143. Predicine Lung Cancer Liquid Biops Sales (Unit), Revenue (Million USD) (2018-2022)
Table 144. Predicine Strategic initiatives
